Eton Pharmaceuticals Overview

  • Founded
  • 2017
Founded
  • Status
  • Public
  • Employees
  • 16
Employees
  • Stock Symbol
  • ETON
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $5.33
  • (As of Tuesday Closing)

Eton Pharmaceuticals General Information

Description

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has a diversified pipeline of around eight product candidates in various stages of development.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 21925 West Field Parkway
  • Suite 235
  • Deer Park, IL 60010-7278
  • United States
+1 (847) 000-0000

Eton Pharmaceuticals Timeline

2018201920202021
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Eton Pharmaceuticals Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$5.33 $5.15 $4.03 - $10.30 $131M 24.6M 365K -$0.51

Eton Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 133,012 196,531 116,487 122,319
Revenue 14,884 39 959 0
EBITDA (9,543) (26,460) (18,154) (12,841)
Net Income (11,091) (27,970) (18,320) (12,740)
Total Assets 29,906 26,319 17,072 28,327
Total Debt 6,813 7,142 4,559 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Eton Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Eton Pharmaceuticals‘s full profile, request access.

Request a free trial

Eton Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Eton Pharmaceuticals‘s full profile, request access.

Request a free trial

Eton Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing
Drug Discovery
Deer Park, IL
16 As of 2020
000.00
000000000 000.00

000000 0

enderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupi
000000000000000
Rehovot, Israel
00 As of 0000
000.00
000000&0 000.00

00000 00

exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repr
0000 000000000
Saint Laurent, Canada
0 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Eton Pharmaceuticals Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Foamix Pharmaceuticals Formerly PE-Backed Rehovot, Israel 00 000.00 000000&0 000.00
00000 000000000000 Corporation Saint Laurent, Canada 0 000.00 000000000 000.00
000000 000000 Corporate Backed or Acquired Nashville, TN 000 000.00 000000000 000.00
000000 00000000000 Formerly VC-backed Westlake Village, CA 00 00000 0000000000.
0000000 0000000000 Private Equity-Backed Pune, India 000 000.00 000000000 000.00
You’re viewing 5 of 7 competitors. Get the full list »

Eton Pharmaceuticals Patents

Eton Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190388498-A1 Ready-to-use oxytocin formulation and uses thereof Abandoned 20-Jun-2018 000000000
US-10004700-B1 More potent and less toxic formulations of epinephrine and methods of medical use Active 16-May-2017 0000000000 0
US-20180333374-A1 More potent and less toxic formulations of epinephrine and methods of medical use Pending 16-May-2017 0000000000 0
JP-2019530727-A Powder for oral suspension containing lamotrigine Pending 11-Oct-2016 0000000000
US-10653626-B2 Powder for oral suspension containing lamotrigine Active 11-Oct-2016 A61K9/1623 00

Eton Pharmaceuticals Executive Team (5)

Name Title Board Seat Contact Info
Sean Brynjelsen Chief Executive Officer & Board Member
Wilson Troutman Chief Financial Officer
Ingrid Hoos Senior Vice President, Regulatory Affairs
David Krempa Vice President, Business Development
Scott Grossenbach Vice President, Sales & Marketing
To view Eton Pharmaceuticals’s complete executive team members history, request access »

Eton Pharmaceuticals Board Members (5)

Name Representing Role Since
Charles Casamento Eton Pharmaceuticals Board Member 000 0000
Norbert Riedel Ph.D Self Chairman & Board Member 000 0000
Paul Maier Self Board Member 000 0000
Sean Brynjelsen Eton Pharmaceuticals Chief Executive Officer & Board Member 000 0000
You’re viewing 4 of 5 board members. Get the full list »

Eton Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Eton Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Eton Pharmaceuticals‘s full profile, request access.

Request a free trial

Eton Pharmaceuticals Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00000 (0.0 27-Mar-2020 000000000 00000 00 00.00 Buildings and Property 0000 0000000000
To view Eton Pharmaceuticals’s complete investments history, request access »